Results for tag: "Zyclara"

Zyclara is a topical cream used to treat actinic keratosis, a precancerous skin condition caused by sun exposure. It is a brand name for the drug imiquimod, which is a type of immune response modifier. Zyclara works by stimulating the body's own immune system to fight the abnormal skin cells. It is applied directly to the affected area and can be used for up to 8 weeks. Common side effects include redness, itching, burning, and swelling. The Zyclara market is a subset of the larger skin cancer drugs market. It is a growing market, driven by increasing awareness of skin cancer and the need for effective treatments. The market is expected to continue to grow as more people become aware of the risks of skin cancer and the need for early detection and treatment. Companies in the Zyclara market include 3M, Allergan, Galderma, and Merz Pharmaceuticals. Show Less Read more